HeartFlow
PublicHeartFlow is now publicly traded
The data on this page reflects HeartFlow's private-market history up to the point it went public, including its funding rounds, valuation, and investors.
Went Public
Aug 11, 2025
Last Round
Convertible Debt
Mar 26, 2025
Total Funding Raised
$1.16B
Company Overview
HeartFlow is a healthcare technology company that offers a cardiac diagnostic platform aimed at revolutionizing the diagnosis and management of coronary artery diseases by utilizing data from standard CT scans to create personalized 3D models of arteries and assess the effects of blockages on blood flow.
Sector
Healthcare/Wellness
Verticals
HealthTech, Life Sciences, TMT
AI Layer
Application
Keywords
HeartFlow Comparables
Compare HeartFlow with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| RapidAI | 64% | |
| Shukun Technology | 64% | |
| AI Medic Inc. | 64% |
HeartFlow Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| IPO | Aug 11, 2025 | ||||
| Convertible Debt | Mar 26, 2025 | ||||
| Series F | Apr 6, 2023 | ||||
| Series E Extension | Jun 14, 2019 | ||||
| Series E | Feb 14, 2018 | ||||
Series D | May 20, 2016 |
HeartFlow Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Bain Capital Life Sciences | Convertible Debt, Series F |
| Janus Henderson Group | Convertible Debt, Series F |
| HealthCor Partners Management | Series F, Series D |
| Capricorn Investment Group | Series F, Series D, Convertible Debt |
| Fidelity Management & Research Company | Convertible Debt |
| Hayfin Capital Management | Series F, Series D |
| U.S. Venture Partners | Series F, Series D |
Recent news
Latest coverage and updates
- has_revenueAug 14, 2026
HeartFlow, Inc. had revenue of $64.1M on Aug 14th '26.
- has_valuationAug 1, 2026
HeartFlow, Inc. had valuation of $2.18B on Aug 1st '26.
- attends_eventJul 20, 2026
HeartFlow, Inc. attends event SCCT2026.
- launchesJul 20, 2026
HeartFlow, Inc. launches AI-powered staging tool for coronary plaque assessments at SCCT2026.
HeartFlow Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request access